open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:
Get Citation

Measurement of radiosensitivity in cervical tumours on the basis of the comet assay

B. Biesaga, A. Gasińska
DOI: 10.1016/S1428-2267(97)70108-X
·
Rep Pract Oncol Radiother 1997;2(2):36.

open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:

Abstract

Purpose

The aim of the study was the radiosensitivity assesment in squamous cell carcinoma (SCC) of the cervix on the basis of the comet assay in which the number of primary and residual DNA damage after 2 Gy dose of the radiation was measured.

Material

19 SCC were studied. The patients were not treated with chemo-or radiotherapy before biopsy.

Method

Single cell suspension from a biopsy was made by digesting with collagenase. The cell suspension was irradiated with doses 0–4 Gy. After the irradiation (initial DNA damage), or after 15 and 60 minuts of incubation at 37°C (residual DNA damage) cell suspension was mixed with poliakrylamide gel. Smears were made and cells were lysed with alkalic solution. Then electraphoresis was performed. The amount of damaged DNA stained with DAPI was measured with image analysis and Comet 3.0 pragramme. The measure of the DNA damage was tail moment, that is the length of comet tail and intesitivity of its fluorescence.

Results

The differences in the number of primary (0 Gy), initial and residual DNA damage in the examined tumours were shown. Linear ralationship between number of initial DNA damage and radiation dose was obtained. Taxonomic analysis of initial DNA damage allowed for identification of 3 groups of patients of statisticaly different sensitivity. After 2 Gy dose of radiation, statisticaly differences in residual DNA damage after 0 and 15 minuts and 0 and 60 minuts were shown. The differences between patients were shown on the basis of the efficacy of the DNA damage repair (range 8.66%–91.73%).

Conclusion

The comet assay seems to have the potential to be used as a predictive assay of individual radiosensitivity.

Abstract

Purpose

The aim of the study was the radiosensitivity assesment in squamous cell carcinoma (SCC) of the cervix on the basis of the comet assay in which the number of primary and residual DNA damage after 2 Gy dose of the radiation was measured.

Material

19 SCC were studied. The patients were not treated with chemo-or radiotherapy before biopsy.

Method

Single cell suspension from a biopsy was made by digesting with collagenase. The cell suspension was irradiated with doses 0–4 Gy. After the irradiation (initial DNA damage), or after 15 and 60 minuts of incubation at 37°C (residual DNA damage) cell suspension was mixed with poliakrylamide gel. Smears were made and cells were lysed with alkalic solution. Then electraphoresis was performed. The amount of damaged DNA stained with DAPI was measured with image analysis and Comet 3.0 pragramme. The measure of the DNA damage was tail moment, that is the length of comet tail and intesitivity of its fluorescence.

Results

The differences in the number of primary (0 Gy), initial and residual DNA damage in the examined tumours were shown. Linear ralationship between number of initial DNA damage and radiation dose was obtained. Taxonomic analysis of initial DNA damage allowed for identification of 3 groups of patients of statisticaly different sensitivity. After 2 Gy dose of radiation, statisticaly differences in residual DNA damage after 0 and 15 minuts and 0 and 60 minuts were shown. The differences between patients were shown on the basis of the efficacy of the DNA damage repair (range 8.66%–91.73%).

Conclusion

The comet assay seems to have the potential to be used as a predictive assay of individual radiosensitivity.

Get Citation
About this article
Title

Measurement of radiosensitivity in cervical tumours on the basis of the comet assay

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 2, No 2 (1997)

Pages

36

Published online

1997-01-01

DOI

10.1016/S1428-2267(97)70108-X

Bibliographic record

Rep Pract Oncol Radiother 1997;2(2):36.

Authors

B. Biesaga
A. Gasińska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl